RxDoctor Payments DataLook up a doctor →

Vuong Nayima, DO

Allergy & Immunology · West Des Moines, IANPI 1174817134

Payments from drug & device makers

$33,749in general payments, 2019–2025

Across 405 payments — averaging $83.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$25K
  • Amgen$2K
  • Sanofi$771
  • Pfizer$749
  • Grifols USA, LLC$609
  • Pharming Healthcare, Inc.$445
  • plus $4K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca104$25,412
Amgen(2 entities)6$1,982
Sanofi51$771
Pfizer29$749
Grifols USA, LLC29$609
Pharming Healthcare, Inc.18$445
Takeda Pharmaceuticals U.S.A., Inc.23$429
Regeneron Healthcare Solutions, Inc.15$365
CSL Behring17$357
Biocryst US Sales Co., LLC16$304
GSK13$251
Biomarin Pharmaceutical Inc.9$222
Jubilant Hollisterstier LLC2$180
Genentech USA, Inc.10$173
Novartis6$157
Genentech, Inc.2$153
Incyte Corporation3$131
Sanofi-aventis U.S. LLC2$115
LEO Pharma Inc.4$106
Octapharma USA, Inc.4$92
Lilly USA, LLC3$86
Kaleo, Inc.4$63
Boehringer Ingelheim4$62
ARS Pharmaceuticals Operations, Inc.4$60
Bio Products Laboratory USA, Inc.4$48
Galderma Laboratories, L.p.3$48
Blueprint Medicines Corporation2$47
Ionis Pharmaceuticals, Inc.2$40
Insmed, Inc.2$34
Alk-abello, Inc1$33
GC Biopharma USA, Inc.2$31
Teva Pharmaceuticals USA, Inc.2$27
Aimmune Therapeutics, Inc.1$25
Kedrion Biopharma, Inc.1$24
Paratek Pharmaceuticals, Inc.1$21
Cycle Pharmaceuticals Inc1$18
Covis Pharma GmbH1$17
Biocryst Pharmaceuticals, Inc.1$15
ADMA Biomanufacturing LLC1$15
Krystal Biotech Inc1$15
Shire North American Group Inc1$14

How this compares

$33,749 in reported general payments places this provider in the 80th percentile of 32 allergy & immunology providers in Iowa.

See all allergy & immunology providers in Iowa →

Medicare billing

Part B allowed, 2024
$90,314
Medicare patients
165
Services billed
9,761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in West Des Moines

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →